topicBergamot Lipid Profile Randomized Trial
claimBergamot ( Citrus bergamia ), a flavonoid-rich nutraceutical, has shown potential cardiometabolic benefits, yet evidence from human trials remains inconsistent.
evidence level1
citationChambari M (2026)
sourceBergamot (<i>Citrus bergamia</i>) Supplementation and Cardiovascular Disease Risk Factors: A Systematic Review and Meta-Analysis.
topicBergamot Lipid Profile Randomized Trial
claimThis systematic review and dose-response meta-analysis evaluated the effects of bergamot ( Citrus bergamia ) on cardiovascular disease risk factors in adults.
evidence level1
citationChambari M (2026)
sourceBergamot (<i>Citrus bergamia</i>) Supplementation and Cardiovascular Disease Risk Factors: A Systematic Review and Meta-Analysis.
topicBergamot Lipid Profile Randomized Trial
claimThe certainty of evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach.
evidence level1
citationChambari M (2026)
sourceBergamot (<i>Citrus bergamia</i>) Supplementation and Cardiovascular Disease Risk Factors: A Systematic Review and Meta-Analysis.
topicBergamot Lipid Profile Randomized Trial
claimIntroduction According to the common definition, nutraceuticals are components found in food that can act as therapeutic substances.
evidence level1
citationMorze J (2020)
sourceComparative effect of nutraceuticals on lipid profile: a protocol for systematic review and network meta-analysis.
topicBergamot Lipid Profile Randomized Trial
claimEach stage of the review, including the study section, data extraction, and risk of bias and quality of evidence assessments, will be performed in duplicate.
evidence level1
citationMorze J (2020)
sourceComparative effect of nutraceuticals on lipid profile: a protocol for systematic review and network meta-analysis.
topicBergamot Lipid Profile Randomized Trial
claimRecently, the International Lipid Expert Panel published two position papers covering the topic of lipid-lowering nutraceuticals and their potential use as a complementary treatment in addition to statins or as an alternative treatment in statin-intolerant patients.
evidence level1
citationMorze J (2020)
sourceComparative effect of nutraceuticals on lipid profile: a protocol for systematic review and network meta-analysis.